Abbott Laboratories (ABT) Capital Expenditure: History & Chart

Abbott Laboratories(ABT)

Medical - Devices · Abbott Park, IL

$105.25+0.00 (+0.00%)

Delayed quote: Sep 9, 2026, 4:00 PM EDT

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL

115,000 employees

www.abbott.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert Ford

View full financials

Capital Expenditures

The latest quarterly capex is $399.00 Million. Capital Expenditures (CapEx) represents spending on physical assets like property, plant, equipment, and technology infrastructure. It's the investment in the company's future productive capacity.

Depreciation|PP&E|Free Cash Flow|Acquisitions|Cash Flow

CapEx

ABT CapEx

$399.00M

Reported quarterly capital expenditures; no daily interpolation. Quarter ended Jun 2026 (2026-06-30): $399.00M.

+227.88% over 10Y

Current CapEx

$399.00M

$399.00 Million

QoQ Growth

N/A

Historical Data

Quarters of data available

Quarterly CapEx History

Period	CapEx	QoQ Growth	YoY Growth
Quarter ended Jun 2026Period end 2026-06-30	$399.00M	N/A	N/A
Quarter ended Mar 2026Period end 2026-03-31	−$399.00M	N/A	N/A
Quarter ended Dec 2025Period end 2025-12-31	−$689.00M	N/A	N/A
Quarter ended Sep 2025Period end 2025-09-30	−$496.00M	N/A	N/A
Quarter ended Jun 2025Period end 2025-06-30	−$502.00M	N/A	N/A
Quarter ended Mar 2025Period end 2025-03-31	−$484.00M	N/A	N/A
Quarter ended Dec 2024Period end 2024-12-31	−$720.00M	N/A	N/A
Quarter ended Sep 2024Period end 2024-09-30	−$556.00M	N/A	N/A
Quarter ended Jun 2024Period end 2024-06-30	−$533.00M	N/A	N/A
Quarter ended Mar 2024Period end 2024-03-31	−$398.00M	N/A	N/A
Quarter ended Dec 2023Period end 2023-12-31	−$755.00M	N/A	N/A
Quarter ended Sep 2023Period end 2023-09-30	−$560.00M	N/A	N/A
Quarter ended Jun 2023Period end 2023-06-30	−$507.00M	N/A	N/A
Quarter ended Mar 2023Period end 2023-03-31	−$380.00M	N/A	N/A
Quarter ended Dec 2022Period end 2022-12-31	−$610.00M	N/A	N/A
Quarter ended Sep 2022Period end 2022-09-30	−$467.00M	N/A	N/A
Quarter ended Jun 2022Period end 2022-06-30	−$379.00M	N/A	N/A
Quarter ended Mar 2022Period end 2022-03-31	−$321.00M	N/A	N/A
Quarter ended Dec 2021Period end 2021-12-31	−$614.00M	N/A	N/A
Quarter ended Sep 2021Period end 2021-09-30	−$461.00M	N/A	N/A
Quarter ended Jun 2021Period end 2021-06-30	−$413.00M	N/A	N/A
Quarter ended Mar 2021Period end 2021-03-31	−$397.00M	N/A	N/A
Quarter ended Dec 2020Period end 2020-12-31	−$679.00M	N/A	N/A
Quarter ended Sep 2020Period end 2020-09-30	−$496.00M	N/A	N/A
Quarter ended Jun 2020Period end 2020-06-30	−$642.00M	N/A	N/A
Quarter ended Mar 2020Period end 2020-03-31	−$360.00M	N/A	N/A
Quarter ended Dec 2019Period end 2019-12-31	−$434.00M	N/A	N/A
Quarter ended Sep 2019Period end 2019-09-30	−$401.00M	N/A	N/A
Quarter ended Jun 2019Period end 2019-06-30	−$468.00M	N/A	N/A
Quarter ended Mar 2019Period end 2019-03-31	−$335.00M	N/A	N/A
Quarter ended Dec 2018Period end 2018-12-31	−$467.00M	N/A	N/A
Quarter ended Sep 2018Period end 2018-09-30	−$354.00M	N/A	N/A
Quarter ended Jun 2018Period end 2018-06-30	−$298.00M	N/A	N/A
Quarter ended Mar 2018Period end 2018-03-31	−$275.00M	N/A	N/A
Quarter ended Dec 2017Period end 2017-12-31	−$345.00M	N/A	N/A
Quarter ended Sep 2017Period end 2017-09-30	−$263.00M	N/A	N/A
Quarter ended Jun 2017Period end 2017-06-30	−$255.00M	N/A	N/A
Quarter ended Mar 2017Period end 2017-03-31	−$272.00M	N/A	N/A
Quarter ended Dec 2016Period end 2016-12-31	−$319.00M	N/A	N/A
Quarter ended Sep 2016Period end 2016-09-30	−$312.00M	N/A	N/A
Quarter ended Jun 2016Period end 2016-06-30	−$247.00M	N/A	N/A
Quarter ended Mar 2016Period end 2016-03-31	−$243.00M	N/A	N/A
Quarter ended Dec 2015Period end 2015-12-31	−$248.00M	N/A	N/A
Quarter ended Sep 2015Period end 2015-09-30	−$411.00M	N/A	N/A
Quarter ended Jun 2015Period end 2015-06-30	−$216.00M	N/A	N/A
Quarter ended Mar 2015Period end 2015-03-31	−$235.00M	N/A	N/A
Quarter ended Dec 2014Period end 2014-12-31	−$287.00M	N/A	N/A
Quarter ended Sep 2014Period end 2014-09-30	−$277.00M	N/A	N/A
Quarter ended Jun 2014Period end 2014-06-30	−$258.00M	N/A	N/A
Quarter ended Mar 2014Period end 2014-03-31	−$255.00M	N/A	N/A
Quarter ended Dec 2013Period end 2013-12-31	−$303.66M	N/A	N/A
Quarter ended Sep 2013Period end 2013-09-30	−$276.46M	N/A	N/A
Quarter ended Jun 2013Period end 2013-06-30	−$290.42M	N/A	N/A
Quarter ended Mar 2013Period end 2013-03-31	−$274.46M	N/A	N/A
Quarter ended Dec 2012Period end 2012-12-31	−$386.10M	N/A	N/A
Quarter ended Sep 2012Period end 2012-09-30	−$530.75M	N/A	N/A
Quarter ended Jun 2012Period end 2012-06-30	−$425.12M	N/A	N/A
Quarter ended Mar 2012Period end 2012-03-31	−$453.33M	N/A	N/A
Quarter ended Dec 2011Period end 2011-12-31	−$274.74M	N/A	N/A
Quarter ended Sep 2011Period end 2011-09-30	−$452.00M	N/A	N/A
Quarter ended Jun 2011Period end 2011-06-30	−$372.96M	N/A	N/A
Quarter ended Mar 2011Period end 2011-03-31	−$391.81M	N/A	N/A
Quarter ended Dec 2010Period end 2010-12-31	−$291.33M	N/A	N/A
Quarter ended Sep 2010Period end 2010-09-30	−$205.09M	N/A	N/A
Quarter ended Jun 2010Period end 2010-06-30	−$273.51M	N/A	N/A
Quarter ended Mar 2010Period end 2010-03-31	−$245.14M	N/A	N/A
Quarter ended Dec 2009Period end 2009-12-31	−$245.45M	N/A	N/A
Quarter ended Sep 2009Period end 2009-09-30	−$328.71M	N/A	N/A
Quarter ended Jun 2009Period end 2009-06-30	−$262.74M	N/A	N/A
Quarter ended Mar 2009Period end 2009-03-31	−$252.15M	N/A	N/A
Quarter ended Dec 2008Period end 2008-12-31	−$264.59M	N/A	N/A
Quarter ended Sep 2008Period end 2008-09-30	−$319.81M	N/A	N/A
Quarter ended Jun 2008Period end 2008-06-30	−$370.34M	N/A	N/A
Quarter ended Mar 2008Period end 2008-03-31	−$332.98M	N/A	N/A
Quarter ended Dec 2007Period end 2007-12-31	−$428.78M	N/A	N/A
Quarter ended Sep 2007Period end 2007-09-30	−$387.58M	N/A	N/A
Quarter ended Jun 2007Period end 2007-06-30	−$510.73M	N/A	N/A
Quarter ended Mar 2007Period end 2007-03-31	−$329.12M	N/A	N/A
Quarter ended Dec 2006Period end 2006-12-31	−$314.12M	N/A	N/A
Quarter ended Sep 2006Period end 2006-09-30	−$352.34M	N/A	N/A
Quarter ended Jun 2006Period end 2006-06-30	−$375.11M	N/A	N/A
Quarter ended Mar 2006Period end 2006-03-31	−$296.25M	N/A	N/A
Quarter ended Dec 2005Period end 2005-12-31	−$311.65M	N/A	N/A
Quarter ended Sep 2005Period end 2005-09-30	−$261.99M	N/A	N/A
Quarter ended Jun 2005Period end 2005-06-30	−$299.71M	N/A	N/A
Quarter ended Mar 2005Period end 2005-03-31	−$334.14M	N/A	N/A
Quarter ended Dec 2004Period end 2004-12-31	−$357.93M	N/A	N/A
Quarter ended Sep 2004Period end 2004-09-30	−$371.92M	N/A	N/A
Quarter ended Jun 2004Period end 2004-06-30	−$198.21M	N/A	N/A
Quarter ended Mar 2004Period end 2004-03-31	−$363.58M	N/A	N/A
Quarter ended Dec 2003Period end 2003-12-31	−$310.47M	N/A	N/A
Quarter ended Sep 2003Period end 2003-09-30	−$341.52M	N/A	N/A
Quarter ended Jun 2003Period end 2003-06-30	−$309.84M	N/A	N/A
Quarter ended Mar 2003Period end 2003-03-31	−$284.91M	N/A	N/A
Quarter ended Dec 2002Period end 2002-12-31	−$386.29M	N/A	N/A
Quarter ended Sep 2002Period end 2002-09-30	−$309.62M	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.

Data as of June 30, 2026